nodes	percent_of_prediction	percent_of_DWPC	metapath
Foscarnet—Creatinine low—Thalidomide—leprosy	0.0498	0.0498	CcSEcCtD
Foscarnet—Blood creatinine decreased—Thalidomide—leprosy	0.0456	0.0456	CcSEcCtD
Foscarnet—Hypoproteinaemia—Thalidomide—leprosy	0.0325	0.0325	CcSEcCtD
Foscarnet—Albuminuria—Dapsone—leprosy	0.025	0.025	CcSEcCtD
Foscarnet—Meningitis—Thalidomide—leprosy	0.0246	0.0246	CcSEcCtD
Foscarnet—Dementia—Thalidomide—leprosy	0.0233	0.0233	CcSEcCtD
Foscarnet—Electrolyte imbalance—Thalidomide—leprosy	0.0229	0.0229	CcSEcCtD
Foscarnet—Grand mal convulsion—Thalidomide—leprosy	0.0201	0.0201	CcSEcCtD
Foscarnet—Lactic dehydrogenase activity increased—Thalidomide—leprosy	0.0187	0.0187	CcSEcCtD
Foscarnet—Vesiculobullous rash—Thalidomide—leprosy	0.017	0.017	CcSEcCtD
Foscarnet—Inappropriate antidiuretic hormone secretion—Thalidomide—leprosy	0.0164	0.0164	CcSEcCtD
Foscarnet—Blood lactate dehydrogenase increased—Thalidomide—leprosy	0.0164	0.0164	CcSEcCtD
Foscarnet—Serum creatinine increased—Thalidomide—leprosy	0.0155	0.0155	CcSEcCtD
Foscarnet—Hypomagnesaemia—Thalidomide—leprosy	0.015	0.015	CcSEcCtD
Foscarnet—Seborrhoeic dermatitis—Thalidomide—leprosy	0.014	0.014	CcSEcCtD
Foscarnet—Thrombosis—Thalidomide—leprosy	0.0135	0.0135	CcSEcCtD
Foscarnet—Stupor—Thalidomide—leprosy	0.0128	0.0128	CcSEcCtD
Foscarnet—Albuminuria—Thalidomide—leprosy	0.0128	0.0128	CcSEcCtD
Foscarnet—Skin ulcer—Thalidomide—leprosy	0.0123	0.0123	CcSEcCtD
Foscarnet—Rash pustular—Thalidomide—leprosy	0.012	0.012	CcSEcCtD
Foscarnet—Muscular weakness—Dapsone—leprosy	0.0119	0.0119	CcSEcCtD
Foscarnet—Pancreatitis—Dapsone—leprosy	0.0115	0.0115	CcSEcCtD
Foscarnet—Skin discolouration—Thalidomide—leprosy	0.0106	0.0106	CcSEcCtD
Foscarnet—Hypocalcaemia—Thalidomide—leprosy	0.0104	0.0104	CcSEcCtD
Foscarnet—Neuropathy peripheral—Dapsone—leprosy	0.0102	0.0102	CcSEcCtD
Foscarnet—Sinusitis—Dapsone—leprosy	0.00979	0.00979	CcSEcCtD
Foscarnet—Coordination abnormal—Thalidomide—leprosy	0.00972	0.00972	CcSEcCtD
Foscarnet—Phosphatase alkaline increased—Thalidomide—leprosy	0.00955	0.00955	CcSEcCtD
Foscarnet—Pharyngitis—Dapsone—leprosy	0.0093	0.0093	CcSEcCtD
Foscarnet—Depressed level of consciousness—Thalidomide—leprosy	0.00922	0.00922	CcSEcCtD
Foscarnet—Candida infection—Thalidomide—leprosy	0.00912	0.00912	CcSEcCtD
Foscarnet—Blood urea increased—Thalidomide—leprosy	0.00902	0.00902	CcSEcCtD
Foscarnet—Neuropathy—Thalidomide—leprosy	0.00897	0.00897	CcSEcCtD
Foscarnet—Cramps of lower extremities—Thalidomide—leprosy	0.00877	0.00877	CcSEcCtD
Foscarnet—Rash maculo-papular—Thalidomide—leprosy	0.00868	0.00868	CcSEcCtD
Foscarnet—Sepsis—Thalidomide—leprosy	0.00829	0.00829	CcSEcCtD
Foscarnet—Lymphadenopathy—Thalidomide—leprosy	0.00812	0.00812	CcSEcCtD
Foscarnet—Blood alkaline phosphatase increased—Thalidomide—leprosy	0.00797	0.00797	CcSEcCtD
Foscarnet—Eye pain—Thalidomide—leprosy	0.00768	0.00768	CcSEcCtD
Foscarnet—Renal failure acute—Thalidomide—leprosy	0.00751	0.00751	CcSEcCtD
Foscarnet—Amnesia—Thalidomide—leprosy	0.00738	0.00738	CcSEcCtD
Foscarnet—Dermatitis bullous—Thalidomide—leprosy	0.00725	0.00725	CcSEcCtD
Foscarnet—Cough—Dapsone—leprosy	0.00712	0.00712	CcSEcCtD
Foscarnet—Hyponatraemia—Thalidomide—leprosy	0.00696	0.00696	CcSEcCtD
Foscarnet—Face oedema—Thalidomide—leprosy	0.00669	0.00669	CcSEcCtD
Foscarnet—Cardiac arrest—Thalidomide—leprosy	0.00659	0.00659	CcSEcCtD
Foscarnet—Ataxia—Thalidomide—leprosy	0.00652	0.00652	CcSEcCtD
Foscarnet—Blood creatinine increased—Thalidomide—leprosy	0.00649	0.00649	CcSEcCtD
Foscarnet—Dehydration—Thalidomide—leprosy	0.00645	0.00645	CcSEcCtD
Foscarnet—Hypokalaemia—Thalidomide—leprosy	0.00631	0.00631	CcSEcCtD
Foscarnet—Toxic epidermal necrolysis—Thalidomide—leprosy	0.00624	0.00624	CcSEcCtD
Foscarnet—Aspartate aminotransferase increased—Thalidomide—leprosy	0.00624	0.00624	CcSEcCtD
Foscarnet—Alanine aminotransferase increased—Thalidomide—leprosy	0.00611	0.00611	CcSEcCtD
Foscarnet—Muscular weakness—Thalidomide—leprosy	0.00611	0.00611	CcSEcCtD
Foscarnet—Insomnia—Dapsone—leprosy	0.00602	0.00602	CcSEcCtD
Foscarnet—Dysphagia—Thalidomide—leprosy	0.00599	0.00599	CcSEcCtD
Foscarnet—Bronchospasm—Thalidomide—leprosy	0.00589	0.00589	CcSEcCtD
Foscarnet—Pancreatitis—Thalidomide—leprosy	0.00587	0.00587	CcSEcCtD
Foscarnet—Pancytopenia—Thalidomide—leprosy	0.00569	0.00569	CcSEcCtD
Foscarnet—Neutropenia—Thalidomide—leprosy	0.0056	0.0056	CcSEcCtD
Foscarnet—Gastrointestinal pain—Dapsone—leprosy	0.00544	0.00544	CcSEcCtD
Foscarnet—Weight decreased—Thalidomide—leprosy	0.00542	0.00542	CcSEcCtD
Foscarnet—Stevens-Johnson syndrome—Thalidomide—leprosy	0.0053	0.0053	CcSEcCtD
Foscarnet—Body temperature increased—Dapsone—leprosy	0.00526	0.00526	CcSEcCtD
Foscarnet—Abdominal pain—Dapsone—leprosy	0.00526	0.00526	CcSEcCtD
Foscarnet—Renal failure—Thalidomide—leprosy	0.00525	0.00525	CcSEcCtD
Foscarnet—Neuropathy peripheral—Thalidomide—leprosy	0.00524	0.00524	CcSEcCtD
Foscarnet—Conjunctivitis—Thalidomide—leprosy	0.00519	0.00519	CcSEcCtD
Foscarnet—Haematuria—Thalidomide—leprosy	0.00509	0.00509	CcSEcCtD
Foscarnet—Sinusitis—Thalidomide—leprosy	0.00501	0.00501	CcSEcCtD
Foscarnet—Agranulocytosis—Thalidomide—leprosy	0.00499	0.00499	CcSEcCtD
Foscarnet—Rhinitis—Thalidomide—leprosy	0.00481	0.00481	CcSEcCtD
Foscarnet—Hypoaesthesia—Thalidomide—leprosy	0.00477	0.00477	CcSEcCtD
Foscarnet—Pharyngitis—Thalidomide—leprosy	0.00476	0.00476	CcSEcCtD
Foscarnet—Urethral disorder—Thalidomide—leprosy	0.0047	0.0047	CcSEcCtD
Foscarnet—Erythema multiforme—Thalidomide—leprosy	0.00453	0.00453	CcSEcCtD
Foscarnet—Eye disorder—Thalidomide—leprosy	0.00448	0.00448	CcSEcCtD
Foscarnet—Chills—Thalidomide—leprosy	0.0043	0.0043	CcSEcCtD
Foscarnet—Vomiting—Dapsone—leprosy	0.00423	0.00423	CcSEcCtD
Foscarnet—Headache—Dapsone—leprosy	0.00417	0.00417	CcSEcCtD
Foscarnet—Flatulence—Thalidomide—leprosy	0.00411	0.00411	CcSEcCtD
Foscarnet—Tension—Thalidomide—leprosy	0.0041	0.0041	CcSEcCtD
Foscarnet—Nervousness—Thalidomide—leprosy	0.00405	0.00405	CcSEcCtD
Foscarnet—Back pain—Thalidomide—leprosy	0.00404	0.00404	CcSEcCtD
Foscarnet—Muscle spasms—Thalidomide—leprosy	0.00401	0.00401	CcSEcCtD
Foscarnet—Nausea—Dapsone—leprosy	0.00395	0.00395	CcSEcCtD
Foscarnet—Tremor—Thalidomide—leprosy	0.00391	0.00391	CcSEcCtD
Foscarnet—Ill-defined disorder—Thalidomide—leprosy	0.00387	0.00387	CcSEcCtD
Foscarnet—Anaemia—Thalidomide—leprosy	0.00386	0.00386	CcSEcCtD
Foscarnet—Agitation—Thalidomide—leprosy	0.00384	0.00384	CcSEcCtD
Foscarnet—Malaise—Thalidomide—leprosy	0.00376	0.00376	CcSEcCtD
Foscarnet—Leukopenia—Thalidomide—leprosy	0.00374	0.00374	CcSEcCtD
Foscarnet—Palpitations—Thalidomide—leprosy	0.00369	0.00369	CcSEcCtD
Foscarnet—Cough—Thalidomide—leprosy	0.00364	0.00364	CcSEcCtD
Foscarnet—Convulsion—Thalidomide—leprosy	0.00362	0.00362	CcSEcCtD
Foscarnet—Hypertension—Thalidomide—leprosy	0.0036	0.0036	CcSEcCtD
Foscarnet—Arthralgia—Thalidomide—leprosy	0.00355	0.00355	CcSEcCtD
Foscarnet—Myalgia—Thalidomide—leprosy	0.00355	0.00355	CcSEcCtD
Foscarnet—Chest pain—Thalidomide—leprosy	0.00355	0.00355	CcSEcCtD
Foscarnet—Anxiety—Thalidomide—leprosy	0.00354	0.00354	CcSEcCtD
Foscarnet—Discomfort—Thalidomide—leprosy	0.00351	0.00351	CcSEcCtD
Foscarnet—Dry mouth—Thalidomide—leprosy	0.00348	0.00348	CcSEcCtD
Foscarnet—Confusional state—Thalidomide—leprosy	0.00344	0.00344	CcSEcCtD
Foscarnet—Oedema—Thalidomide—leprosy	0.00341	0.00341	CcSEcCtD
Foscarnet—Infection—Thalidomide—leprosy	0.00338	0.00338	CcSEcCtD
Foscarnet—Thrombocytopenia—Thalidomide—leprosy	0.00334	0.00334	CcSEcCtD
Foscarnet—Hyperhidrosis—Thalidomide—leprosy	0.00329	0.00329	CcSEcCtD
Foscarnet—Anorexia—Thalidomide—leprosy	0.00325	0.00325	CcSEcCtD
Foscarnet—Hypotension—Thalidomide—leprosy	0.00318	0.00318	CcSEcCtD
Foscarnet—Musculoskeletal discomfort—Thalidomide—leprosy	0.0031	0.0031	CcSEcCtD
Foscarnet—Insomnia—Thalidomide—leprosy	0.00308	0.00308	CcSEcCtD
Foscarnet—Paraesthesia—Thalidomide—leprosy	0.00306	0.00306	CcSEcCtD
Foscarnet—Dyspnoea—Thalidomide—leprosy	0.00304	0.00304	CcSEcCtD
Foscarnet—Somnolence—Thalidomide—leprosy	0.00303	0.00303	CcSEcCtD
Foscarnet—Dyspepsia—Thalidomide—leprosy	0.003	0.003	CcSEcCtD
Foscarnet—Decreased appetite—Thalidomide—leprosy	0.00296	0.00296	CcSEcCtD
Foscarnet—Fatigue—Thalidomide—leprosy	0.00294	0.00294	CcSEcCtD
Foscarnet—Constipation—Thalidomide—leprosy	0.00291	0.00291	CcSEcCtD
Foscarnet—Pain—Thalidomide—leprosy	0.00291	0.00291	CcSEcCtD
Foscarnet—Feeling abnormal—Thalidomide—leprosy	0.00281	0.00281	CcSEcCtD
Foscarnet—Gastrointestinal pain—Thalidomide—leprosy	0.00279	0.00279	CcSEcCtD
Foscarnet—Abdominal pain—Thalidomide—leprosy	0.00269	0.00269	CcSEcCtD
Foscarnet—Body temperature increased—Thalidomide—leprosy	0.00269	0.00269	CcSEcCtD
Foscarnet—Asthenia—Thalidomide—leprosy	0.00244	0.00244	CcSEcCtD
Foscarnet—Pruritus—Thalidomide—leprosy	0.00241	0.00241	CcSEcCtD
Foscarnet—Diarrhoea—Thalidomide—leprosy	0.00233	0.00233	CcSEcCtD
Foscarnet—Dizziness—Thalidomide—leprosy	0.00225	0.00225	CcSEcCtD
Foscarnet—Vomiting—Thalidomide—leprosy	0.00217	0.00217	CcSEcCtD
Foscarnet—Rash—Thalidomide—leprosy	0.00215	0.00215	CcSEcCtD
Foscarnet—Dermatitis—Thalidomide—leprosy	0.00215	0.00215	CcSEcCtD
Foscarnet—Headache—Thalidomide—leprosy	0.00213	0.00213	CcSEcCtD
Foscarnet—Nausea—Thalidomide—leprosy	0.00202	0.00202	CcSEcCtD
